Chikungunya virus detection in semen
Part of Infections clinical trials.
This study looks for Chikungunya virus in the semen of men who are currently sick with the virus, to understand how long it stays there.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 45 years old.
- You have symptoms like fever, tiredness, rash, joint or muscle pain, headache, red eyes, or eye pain.
- You tested positive for Chikungunya virus in your blood or urine.
- You can travel to the lab for sample collection.
- You can produce a semen sample (at least 1.5 mL).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new vaccine to see if it's safe and helps protect against chikungunya virus (a mosquito-borne illness causing fever and joint pain). It's for healthy adults ages 18 to 60 who haven't recently traveled to areas with similar viruses or received certain other vaccines.
This study looks at how well the VLA1553 vaccine prevents chikungunya disease in parts of Brazil where the vaccine is being offered as part of a pilot program. If you live in one of those areas and have had symptoms that might be chikungunya, this study will use your health records and blood tests to check how effective the vaccine is.
This trial tests a new treatment (PC-CHIK-V) for newborns whose mothers had chikungunya around the time of birth. The goal is to see if the treatment can prevent or reduce the infection in babies. Babies who are not treated will also be followed for comparison.
This study follows pregnant women who received the VLA1553 vaccine (for chikungunya) to see how it affects them and their babies. It compares them to pregnant women who received a different vaccine approved during pregnancy.
This study is for people who are eligible for the chikungunya vaccine in La Réunion. It looks at how well the vaccine works in real life, if it’s safe, and how your body responds to it.
This study tests a new rapid diagnostic tool that can quickly identify tropical fever-causing infections like malaria, dengue, Zika, chikungunya, or leptospirosis from a blood sample. The goal is to help doctors diagnose these infections faster so patients can get treatment sooner.
Hear when a new Chikungunya Virus Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.